MODAFRESH 200

What is MODAFRESH 200?

MODAFRESH 200 is a modern drug from the group of psychostimulant and nootropic agents, which is used to increase wakefulness, improve cognitive functions, and combat excessive daytime sleepiness. The drug is available in the form of tablets for oral use, each of which contains 200 mg of the active substance modafinil. The manufacturer of MODAFRESH 200 is the Indian pharmaceutical company Sunrise Remedies, which specializes in the production of high-quality generic drugs in accordance with international GMP standards. The pharmacological action of the drug is aimed at activating certain areas of the brain responsible for the sleep-wake cycle, thereby achieving a stable effect of alertness without pronounced excitation of the peripheral nervous system. MODAFRESH 200 belongs to prescription drugs, so its use must take place exclusively under the supervision of a doctor after a thorough examination and establishing an accurate diagnosis.

Unlike classic amphetamine-class psychostimulants, MODAFRESH 200 has a fundamentally different mechanism of action, which provides a significantly lower risk of developing addiction and fewer serious side effects. The drug does not cause euphoria, does not provoke sudden mood swings, and does not deplete the reserves of the nervous system when dosed correctly. The therapeutic effect develops gradually within 60–90 minutes after taking the tablet and lasts for 12–15 hours, which allows using the drug once a day. It is important to understand that MODAFRESH 200 does not replace full sleep, but only temporarily masks the feeling of fatigue, so chronic sleep deprivation while taking the drug can lead to negative health consequences. The drug is used in many countries around the world to treat narcolepsy, obstructive sleep apnea, and circadian rhythm disorders associated with shift work schedules.

Sunrise Remedies is a pharmaceutical company from India that has been developing and manufacturing medicines for the international market for over a decade. The company's production facilities are certified in accordance with the requirements of the World Health Organization and international regulatory bodies, which guarantees the stable quality of each batch of products. MODAFRESH 200 undergoes multi-stage quality control at all stages of production — from incoming raw materials to the finished tablet, which ensures the accuracy of dosage and bioavailability of the active substance. The drug is supplied in blisters of 10 tablets, which are packed in a cardboard box with detailed instructions for use in Ukrainian.

What is MODAFRESH 200 prescribed for?

The main indication for the prescription of MODAFRESH 200 is narcolepsy — a chronic neurological disorder characterized by uncontrolled sleep attacks during the day and sudden loss of muscle tone. Patients with narcolepsy suffer from constant daytime sleepiness, which significantly impairs the quality of life, limits professional activities, and creates a risk of dangerous situations when driving or operating machinery. MODAFRESH 200 effectively reduces the frequency and intensity of daytime sleepiness episodes, allowing patients to lead an active lifestyle and maintain productivity throughout the day. The therapeutic effect in narcolepsy is achieved due to the effect of modafinil on the hypothalamic centers regulating the sleep-wake cycle.

The second important indication is obstructive sleep apnea syndrome, in which patients suffer from repeated breathing pauses during sleep, leading to fragmentation of night rest and pronounced daytime sleepiness. MODAFRESH 200 is prescribed as an adjunct to primary therapy, which usually includes the use of continuous positive airway pressure (CPAP) devices. The drug helps to overcome residual sleepiness in those patients who continue to experience fatigue even after the correction of night breathing. It is important to emphasize that MODAFRESH 200 does not treat the apnea itself, but only eliminates its consequence in the form of daytime hypersomnia, so the primary therapy remains mandatory.

MODAFRESH 200 is also used for circadian rhythm sleep disorders, particularly shift work sleep disorder, when a person is forced to work night shifts or frequently change time zones. The drug helps to adapt the body to a new wakefulness schedule, reduces the feeling of fatigue, and improves concentration during periods when the biological clock signals the need for sleep. In some cases, a doctor may prescribe MODAFRESH 200 off-label for the treatment of attention deficit hyperactivity disorder (ADHD) in adults, chronic fatigue in certain neurological diseases, or to enhance cognitive performance in healthy individuals. However, such use requires special caution and a careful weighing of potential benefits and risks.

Composition and active ingredients of MODAFRESH 200

Each MODAFRESH 200 tablet contains 200 mg of modafinil as the active pharmaceutical ingredient, which is a derivative of benzhydrylsulfinylacetamide. Modafinil is a unique molecule that selectively affects the hypothalamus, specifically the neurons that produce orexin and histamine, which are key neurotransmitters of the wakefulness-promoting system. Unlike traditional stimulants, modafinil does not cause a massive release of dopamine in the nucleus accumbens, which explains the low potential for abuse and the absence of a pronounced euphoric effect. The mechanism of action also includes the inhibition of dopamine reuptake in the prefrontal cortex and striatum, which contributes to improved cognitive functions, working memory, and the ability to maintain long-term concentration.

The auxiliary components of MODAFRESH 200 include lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, magnesium stearate, and talc, which ensure the stability of the tablet, its proper disintegration in the gastrointestinal tract, and optimal bioavailability of the active substance. Lactose monohydrate acts as a filler, microcrystalline cellulose provides mechanical strength to the tablet, and croscarmellose sodium promotes rapid disintegration of the tablet after entering the stomach. Povidone acts as a binding agent that evenly distributes modafinil in the tablet mass, while magnesium stearate and talc prevent the powder mixture from sticking to the equipment during compression.

The bioavailability of modafinil when taken orally is about 80%, and the maximum concentration in blood plasma is reached 2–3 hours after taking the tablet. The half-life of the drug is 12–15 hours, which allows it to be used once a day without the need to split the dose. The metabolism of modafinil occurs mainly in the liver with the participation of the cytochrome CYP3A4, and the excretion of metabolites is carried out by the kidneys, so patients with impaired liver or kidney function may require dose adjustment. MODAFRESH 200 does not accumulate in the body when the recommended dosing regimen is observed, which reduces the risk of cumulative toxicity.

Dosage of MODAFRESH 200

The standard recommended dose of MODAFRESH 200 for adult patients is 200 mg once a day, usually in the morning or 1 hour before the start of the work shift. For narcolepsy and obstructive sleep apnea syndrome, the drug is taken in the morning to ensure alertness throughout the day and not to disrupt night sleep. For patients with a shift work schedule, the time of administration is determined individually, depending on when it is necessary to maintain maximum productivity. In some cases, a doctor may prescribe an initial dose of 100 mg per day with subsequent titration to 200 mg depending on individual response and tolerability of the drug.

The maximum daily dose of MODAFRESH 200 should not exceed 400 mg, however, such high doses are used rarely and only if the standard dose is insufficiently effective, under close medical supervision. The duration of the treatment course is determined individually depending on the diagnosis, severity of symptoms, and response to therapy, and can range from several weeks to long-term use over many months. Elderly patients, as well as persons with impaired liver function, are recommended to start therapy with a dose of 100 mg per day and increase it only in the absence of side effects. In severe renal failure, a dose reduction or an increase in the interval between doses may be required.

Abrupt discontinuation of MODAFRESH 200 usually does not cause a pronounced withdrawal syndrome, but a gradual dose reduction is recommended to avoid a temporary return of sleepiness and a decrease in performance. The doctor may recommend reducing the dose by 50 mg every 3–5 days until complete discontinuation of the drug, especially if the therapy lasted for more than a month. It is important not to exceed the prescribed dose on your own, as an overdose of modafinil can cause anxiety, tachycardia, increased blood pressure, and insomnia, which requires symptomatic therapy in a medical facility.

How to take MODAFRESH 200 correctly?

MODAFRESH 200 is taken orally, swallowing the tablet with a sufficient amount of water, regardless of food intake, although taking the drug after a light breakfast can reduce the risk of dyspeptic symptoms. The tablet should be swallowed whole, without chewing or crushing, as breaking the integrity of the tablet can affect the release rate of the active substance and alter the pharmacokinetic profile of the drug. The optimal time of administration is in the morning immediately after waking up or 60–90 minutes before starting activities that require increased concentration and alertness. Taking MODAFRESH 200 in the afternoon or evening can lead to difficulty falling asleep and disruption of the normal sleep cycle, so the recommended time of administration should be strictly observed.

If a regular dose of MODAFRESH 200 is missed, it must be taken as soon as possible if there are more than 8 hours left before the next scheduled dose. If the missed dose is noticed late and the next dose is approaching, the missed dose should be skipped and the regular schedule resumed, without doubling the dose to compensate. Doubling the dose can cause an overdose and increased side effects, so this practice is strongly discouraged. During MODAFRESH 200 therapy, it is important to maintain an adequate fluid intake, as the drug can cause dry mouth and mild dehydration, especially during physical activity or in hot weather.

Patients taking MODAFRESH 200 are advised to keep a well-being diary, recording their alertness level, quality of night sleep, presence of side effects, and overall performance, which will help the doctor evaluate the effectiveness of therapy and adjust the dosage in a timely manner. The drug should not be combined with other stimulants, energy drinks, or large doses of caffeine, as this can lead to excessive stimulation of the nervous system, anxiety, and heart rhythm disturbances. Women of childbearing potential taking MODAFRESH 200 should be aware that modafinil can reduce the effectiveness of hormonal contraceptives, so additional methods of preventing pregnancy must be used during therapy and for one month after its completion.

Side effects of MODAFRESH 200

The most common side effects of MODAFRESH 200, observed in more than 10% of patients, are headache, nervousness, insomnia, and dry mouth. The headache usually occurs at the beginning of therapy and tends to decrease or completely disappear during the first 1–2 weeks of taking the drug. Insomnia is most often associated with the incorrect time of tablet administration, so adjusting the dosing regimen usually resolves this issue without the need for additional prescription of sleeping pills. Dry mouth can be reduced by drinking water regularly, using moisturizing oral sprays, or chewing sugar-free candies that stimulate salivation.

Less common side effects of MODAFRESH 200 include tachycardia, increased blood pressure, decreased appetite, nausea, diarrhea or constipation, as well as anxiety and emotional lability. In rare cases, serious skin reactions can occur, including Stevens-Johnson syndrome and toxic epidermal necrolysis, which require immediate discontinuation of the drug and emergency medical attention. Patients should immediately inform their doctor if they develop a rash, itching, swelling of the face or mucous membranes, difficulty breathing, chest pain, or a pronounced heart rhythm disorder. Rare cases of psychiatric disorders have also been reported, including hallucinations, mania, and suicidal thoughts, which requires special attention in patients with a history of psychiatric disorders.

The body's individual response to MODAFRESH 200 can vary significantly depending on age, gender, genetic characteristics of metabolism, and the presence of concomitant diseases. Some patients may experience a pronounced therapeutic effect even from the minimum dose, while others require the maximum recommended dose to achieve the desired result. The appearance of any unusual symptoms during therapy is a reason to consult a doctor, who will assess the benefit-risk ratio of continuing treatment. Unauthorized discontinuation of the drug without consulting a specialist can lead to the return of symptoms of the underlying disease and a deterioration in the quality of life.

Contraindications of MODAFRESH 200

MODAFRESH 200 has a number of absolute contraindications, in the presence of which the use of the drug is strictly prohibited. These include hypersensitivity to modafinil or any auxiliary component of the tablet, as well as a history of serious allergic reactions to other drugs of this group. The drug is not prescribed to patients with severe cardiovascular diseases, including uncontrolled arterial hypertension, recently suffered myocardial infarction, unstable angina, and clinically significant heart rhythm disturbances. Also, MODAFRESH 200 is contraindicated in severe anxiety, psychomotor agitation, and psychotic disorders, as the stimulating effect of the drug can aggravate these conditions and provoke an exacerbation of psychiatric symptoms.

Pregnancy is an absolute contraindication to the use of MODAFRESH 200, as studies have shown an increased risk of congenital fetal malformations, particularly heart and vascular system defects. Women of childbearing potential are recommended to use reliable methods of contraception during therapy and for at least one month after its completion, given modafinil's ability to reduce the effectiveness of hormonal contraceptives. The breastfeeding period is also a contraindication, as modafinil penetrates into breast milk and can affect the nervous system of the infant. MODAFRESH 200 is not prescribed to children and adolescents under 18 years of age due to the lack of sufficient data on safety and efficacy in this age group.

Relative contraindications require special caution and a careful weighing of potential benefits and risks before prescribing MODAFRESH 200. These include moderate arterial hypertension, ischemic heart disease, liver and kidney dysfunction, epilepsy and other seizure disorders, as well as a history of mental illness. For elderly patients, the drug is prescribed with caution, starting with minimal doses and under close monitoring of blood pressure, heart rate, and general condition. For individuals with a history of substance abuse, MODAFRESH 200 should be prescribed with extreme caution, despite the low potential for drug abuse.

Interaction of MODAFRESH 200 with other medicines and alcohol

MODAFRESH 200 enters into clinically significant interactions with a number of medicines, which may require dose adjustments or complete avoidance of combination therapy. Modafinil is an inducer of cytochrome P450 enzymes, particularly CYP3A4, CYP2C19, and CYP1A2, so it can accelerate metabolism and reduce the effectiveness of hormonal contraceptives, warfarin-type anticoagulants, certain antidepressants, antiepileptic drugs, and immunosuppressants. Co-administration of MODAFRESH 200 with MAO inhibitors, tricyclic antidepressants, and selective serotonin reuptake inhibitors can increase the risk of developing serotonin syndrome, manifested by agitation, tremor, hyperthermia, and impaired consciousness. Patients taking any medications on a regular basis must inform their doctor before starting MODAFRESH 200 therapy.

Alcohol consumption during MODAFRESH 200 therapy is not recommended, as the combination of the stimulating effect of modafinil with the depressant effect of ethanol on the central nervous system can lead to unpredictable reactions. Alcohol can mask or enhance the side effects of the drug, including dizziness, impaired coordination, and decreased reaction speed, which creates an additional risk when driving or operating dangerous machinery. In addition, MODAFRESH 200 can reduce the subjective feeling of intoxication, leading to the consumption of larger doses of alcohol and an increased risk of toxic liver damage. Patients should refrain from driving vehicles until they are sure of the absence of individual side reactions to the drug, such as dizziness or visual impairment.

Where to buy MODAFRESH 200 in Ukraine

MODAFRESH 200 is available in Ukraine through a network of licensed pharmacies that sell the drug exclusively by doctor's prescription, which confirms its status as a prescription-only medicine. The drug can be purchased both in physical pharmacies and through online medicine booking platforms, where the patient can check the availability of MODAFRESH 200 in the nearest pharmacies in advance and reserve the required number of packs. The cost of the drug may vary depending on the region, pharmacy chain, and current pricing policy of distributors, so patients are advised to compare prices in several sources before making a purchase. It is important to buy MODAFRESH 200 only in certified pharmacies, avoiding doubtful online stores and private sellers, as there is a risk of purchasing counterfeit products.

MODAFRESH 200 must be stored in its original packaging at a temperature not exceeding 25°C in a dry place, protected from direct sunlight and out of reach of children. The shelf life of the drug is 24 months from the date of manufacture, after which the use of the tablets is strictly prohibited. Before starting MODAFRESH 200 therapy, a consultation with a doctor is mandatory, who will conduct the necessary examination, establish an accurate diagnosis, rule out contraindications, and determine the optimal dosing regimen taking into account the individual characteristics of the patient. Self-treatment with psychostimulant drugs can lead to serious health consequences, so a responsible attitude to therapy is the key to the safe and effective use of MODAFRESH 200.